Loading…

Structure-Activity Study on the Spatial Arrangement of the Third Aromatic Ring of Endomorphins 1 and 2 Using an Atypical Constrained C Terminus

The discovery of endomorphins (EMs) has opened the possibility of searching for new analgesics. However, the design of peptide analgesics has proven to be very difficult as a result of their conformational flexibility and a lack of clarity in structure–activity relationships (SAR). In EMs, the amino...

Full description

Saved in:
Bibliographic Details
Published in:ChemMedChem 2007-03, Vol.2 (3), p.309-317
Main Authors: Yu, Ye, Shao, Xuan, Cui, Yun, Liu, Hong-mei, Wang, Chang-ling, Fan, Ying-zhe, Liu, Jing, Dong, Shou-liang, Cui, Yu-xing, Wang, Rui
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4064-46bc7129985673ea741a0da7f1ad4b952e69ba577e87dd5d724d1313d43bcd823
cites cdi_FETCH-LOGICAL-c4064-46bc7129985673ea741a0da7f1ad4b952e69ba577e87dd5d724d1313d43bcd823
container_end_page 317
container_issue 3
container_start_page 309
container_title ChemMedChem
container_volume 2
creator Yu, Ye
Shao, Xuan
Cui, Yun
Liu, Hong-mei
Wang, Chang-ling
Fan, Ying-zhe
Liu, Jing
Dong, Shou-liang
Cui, Yu-xing
Wang, Rui
description The discovery of endomorphins (EMs) has opened the possibility of searching for new analgesics. However, the design of peptide analgesics has proven to be very difficult as a result of their conformational flexibility and a lack of clarity in structure–activity relationships (SAR). In EMs, the amino acid side chains exhibit considerable conformational flexibility, especially in the third aromatic ring, which is free to adopt a bioactive conformation. To resolve these problems, a series of C terminus EM analogues, [Xaa4‐R]EMs, modified through the substitution of Phe4 with nonaromatic residues and termination with benzyl groups, were designed to generate conformational constrains of the third aromatic ring by amide bond and torsion angles (ϕ4 and ψ4) of Xaa4. Introduction of (S)‐α‐methyl or (S)/(R)‐α‐carboxamide on the methylene unit of the benzyl group was designed to produce an atypical topographical constraint (ϕ5) of the third aromatic ring rotation. Interestingly, some EM derivatives, with elimination of the C‐terminal carboxamide group and significant changes in the address sequence (Phe4‐NH2), still exhibited higher μ‐opioid receptor (MOR) affinity than unmodified EMs. In contrast, some analogues with incorrectly constrained C termini displayed very low affinity and pharmacological activities. Thus, our results indicate that these EM analogues, with atypical constrained C termini, provide model compounds with potent MOR agonism. They also give evidence that the proper spatial orientation and conformational restriction of the third aromatic ring are crucial for the interaction of EMs with MOR. The C termini of endomorphin analogues, [Xaa4‐R]EMs, modified by substitution of Phe4 with nonaromatic residues and terminated with benzyl groups, were designed to generate conformational constrains of the third aromatic ring by amide bond and torsion angles (ϕ4 and ψ4) of Xaa4.
doi_str_mv 10.1002/cmdc.200600274
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70386070</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70386070</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4064-46bc7129985673ea741a0da7f1ad4b952e69ba577e87dd5d724d1313d43bcd823</originalsourceid><addsrcrecordid>eNqFUU1v0zAYthATG4UrR-QTt3R24tjJsWRjQ9oA0U4cLcd2V0NiZ7YD5MaFH7C_uF8yl1aFG5fXr_V8SO_zAPAKozlGKD-VvZLzHCGaPow8ASe4oihjuGJPDzurj8HzEL4iREiFq2fgGLO8KinFJ-B-Gf0o4-h1tpDRfDdxgss4qgk6C-NGw-UgohEdXHgv7K3utY3Qrf9Aq43xKgGuTxQJPxt7u4XOrXK988PG2AAxFFbBHN6ELSosXMRpMDIZNs6G6IWxWsHm4dfvlfa9sWN4AY7Wogv65f6dgZt356vmMrv6ePG-WVxlkiBKMkJbyXBe1-kQVmjBCBZICbbGQpG2LnNN61aUjOmKKVUqlhOFC1woUrRSVXkxA292voN3d6MOkfcmSN11wmo3Bs5QkeJLcwbmO6L0LgSv13zwphd-4hjxbQl8WwI_lJAEr_fOY9tr9Ze-Tz0R6h3hh-n09B873lyfNf-aZzutCVH_PGiF_8ZTDqzkXz5ccPaJFmf0csnfFo-wc6Ro</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70386070</pqid></control><display><type>article</type><title>Structure-Activity Study on the Spatial Arrangement of the Third Aromatic Ring of Endomorphins 1 and 2 Using an Atypical Constrained C Terminus</title><source>Wiley</source><creator>Yu, Ye ; Shao, Xuan ; Cui, Yun ; Liu, Hong-mei ; Wang, Chang-ling ; Fan, Ying-zhe ; Liu, Jing ; Dong, Shou-liang ; Cui, Yu-xing ; Wang, Rui</creator><creatorcontrib>Yu, Ye ; Shao, Xuan ; Cui, Yun ; Liu, Hong-mei ; Wang, Chang-ling ; Fan, Ying-zhe ; Liu, Jing ; Dong, Shou-liang ; Cui, Yu-xing ; Wang, Rui</creatorcontrib><description>The discovery of endomorphins (EMs) has opened the possibility of searching for new analgesics. However, the design of peptide analgesics has proven to be very difficult as a result of their conformational flexibility and a lack of clarity in structure–activity relationships (SAR). In EMs, the amino acid side chains exhibit considerable conformational flexibility, especially in the third aromatic ring, which is free to adopt a bioactive conformation. To resolve these problems, a series of C terminus EM analogues, [Xaa4‐R]EMs, modified through the substitution of Phe4 with nonaromatic residues and termination with benzyl groups, were designed to generate conformational constrains of the third aromatic ring by amide bond and torsion angles (ϕ4 and ψ4) of Xaa4. Introduction of (S)‐α‐methyl or (S)/(R)‐α‐carboxamide on the methylene unit of the benzyl group was designed to produce an atypical topographical constraint (ϕ5) of the third aromatic ring rotation. Interestingly, some EM derivatives, with elimination of the C‐terminal carboxamide group and significant changes in the address sequence (Phe4‐NH2), still exhibited higher μ‐opioid receptor (MOR) affinity than unmodified EMs. In contrast, some analogues with incorrectly constrained C termini displayed very low affinity and pharmacological activities. Thus, our results indicate that these EM analogues, with atypical constrained C termini, provide model compounds with potent MOR agonism. They also give evidence that the proper spatial orientation and conformational restriction of the third aromatic ring are crucial for the interaction of EMs with MOR. The C termini of endomorphin analogues, [Xaa4‐R]EMs, modified by substitution of Phe4 with nonaromatic residues and terminated with benzyl groups, were designed to generate conformational constrains of the third aromatic ring by amide bond and torsion angles (ϕ4 and ψ4) of Xaa4.</description><identifier>ISSN: 1860-7179</identifier><identifier>EISSN: 1860-7187</identifier><identifier>DOI: 10.1002/cmdc.200600274</identifier><identifier>PMID: 17285661</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Amides - chemistry ; Amino Acid Sequence ; Analgesics, Opioid - chemistry ; Analgesics, Opioid - pharmacology ; Animals ; Drug Design ; endomorphins ; Guinea Pigs ; Hydrocarbons, Aromatic - chemistry ; Ileum - drug effects ; Ileum - physiology ; Male ; Mice ; Molecular Sequence Data ; Oligopeptides - chemistry ; Oligopeptides - pharmacology ; opioid receptors ; Protein Conformation ; Receptors, Opioid - agonists ; Receptors, Opioid - metabolism ; Receptors, Opioid, mu - agonists ; Receptors, Opioid, mu - metabolism ; spatial arrangements ; Stereoisomerism ; Structure-Activity Relationship ; synthesis ; Vas Deferens - drug effects ; Vas Deferens - physiology</subject><ispartof>ChemMedChem, 2007-03, Vol.2 (3), p.309-317</ispartof><rights>Copyright © 2007 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4064-46bc7129985673ea741a0da7f1ad4b952e69ba577e87dd5d724d1313d43bcd823</citedby><cites>FETCH-LOGICAL-c4064-46bc7129985673ea741a0da7f1ad4b952e69ba577e87dd5d724d1313d43bcd823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17285661$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Ye</creatorcontrib><creatorcontrib>Shao, Xuan</creatorcontrib><creatorcontrib>Cui, Yun</creatorcontrib><creatorcontrib>Liu, Hong-mei</creatorcontrib><creatorcontrib>Wang, Chang-ling</creatorcontrib><creatorcontrib>Fan, Ying-zhe</creatorcontrib><creatorcontrib>Liu, Jing</creatorcontrib><creatorcontrib>Dong, Shou-liang</creatorcontrib><creatorcontrib>Cui, Yu-xing</creatorcontrib><creatorcontrib>Wang, Rui</creatorcontrib><title>Structure-Activity Study on the Spatial Arrangement of the Third Aromatic Ring of Endomorphins 1 and 2 Using an Atypical Constrained C Terminus</title><title>ChemMedChem</title><addtitle>ChemMedChem</addtitle><description>The discovery of endomorphins (EMs) has opened the possibility of searching for new analgesics. However, the design of peptide analgesics has proven to be very difficult as a result of their conformational flexibility and a lack of clarity in structure–activity relationships (SAR). In EMs, the amino acid side chains exhibit considerable conformational flexibility, especially in the third aromatic ring, which is free to adopt a bioactive conformation. To resolve these problems, a series of C terminus EM analogues, [Xaa4‐R]EMs, modified through the substitution of Phe4 with nonaromatic residues and termination with benzyl groups, were designed to generate conformational constrains of the third aromatic ring by amide bond and torsion angles (ϕ4 and ψ4) of Xaa4. Introduction of (S)‐α‐methyl or (S)/(R)‐α‐carboxamide on the methylene unit of the benzyl group was designed to produce an atypical topographical constraint (ϕ5) of the third aromatic ring rotation. Interestingly, some EM derivatives, with elimination of the C‐terminal carboxamide group and significant changes in the address sequence (Phe4‐NH2), still exhibited higher μ‐opioid receptor (MOR) affinity than unmodified EMs. In contrast, some analogues with incorrectly constrained C termini displayed very low affinity and pharmacological activities. Thus, our results indicate that these EM analogues, with atypical constrained C termini, provide model compounds with potent MOR agonism. They also give evidence that the proper spatial orientation and conformational restriction of the third aromatic ring are crucial for the interaction of EMs with MOR. The C termini of endomorphin analogues, [Xaa4‐R]EMs, modified by substitution of Phe4 with nonaromatic residues and terminated with benzyl groups, were designed to generate conformational constrains of the third aromatic ring by amide bond and torsion angles (ϕ4 and ψ4) of Xaa4.</description><subject>Amides - chemistry</subject><subject>Amino Acid Sequence</subject><subject>Analgesics, Opioid - chemistry</subject><subject>Analgesics, Opioid - pharmacology</subject><subject>Animals</subject><subject>Drug Design</subject><subject>endomorphins</subject><subject>Guinea Pigs</subject><subject>Hydrocarbons, Aromatic - chemistry</subject><subject>Ileum - drug effects</subject><subject>Ileum - physiology</subject><subject>Male</subject><subject>Mice</subject><subject>Molecular Sequence Data</subject><subject>Oligopeptides - chemistry</subject><subject>Oligopeptides - pharmacology</subject><subject>opioid receptors</subject><subject>Protein Conformation</subject><subject>Receptors, Opioid - agonists</subject><subject>Receptors, Opioid - metabolism</subject><subject>Receptors, Opioid, mu - agonists</subject><subject>Receptors, Opioid, mu - metabolism</subject><subject>spatial arrangements</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>synthesis</subject><subject>Vas Deferens - drug effects</subject><subject>Vas Deferens - physiology</subject><issn>1860-7179</issn><issn>1860-7187</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFUU1v0zAYthATG4UrR-QTt3R24tjJsWRjQ9oA0U4cLcd2V0NiZ7YD5MaFH7C_uF8yl1aFG5fXr_V8SO_zAPAKozlGKD-VvZLzHCGaPow8ASe4oihjuGJPDzurj8HzEL4iREiFq2fgGLO8KinFJ-B-Gf0o4-h1tpDRfDdxgss4qgk6C-NGw-UgohEdXHgv7K3utY3Qrf9Aq43xKgGuTxQJPxt7u4XOrXK988PG2AAxFFbBHN6ELSosXMRpMDIZNs6G6IWxWsHm4dfvlfa9sWN4AY7Wogv65f6dgZt356vmMrv6ePG-WVxlkiBKMkJbyXBe1-kQVmjBCBZICbbGQpG2LnNN61aUjOmKKVUqlhOFC1woUrRSVXkxA292voN3d6MOkfcmSN11wmo3Bs5QkeJLcwbmO6L0LgSv13zwphd-4hjxbQl8WwI_lJAEr_fOY9tr9Ze-Tz0R6h3hh-n09B873lyfNf-aZzutCVH_PGiF_8ZTDqzkXz5ccPaJFmf0csnfFo-wc6Ro</recordid><startdate>20070312</startdate><enddate>20070312</enddate><creator>Yu, Ye</creator><creator>Shao, Xuan</creator><creator>Cui, Yun</creator><creator>Liu, Hong-mei</creator><creator>Wang, Chang-ling</creator><creator>Fan, Ying-zhe</creator><creator>Liu, Jing</creator><creator>Dong, Shou-liang</creator><creator>Cui, Yu-xing</creator><creator>Wang, Rui</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070312</creationdate><title>Structure-Activity Study on the Spatial Arrangement of the Third Aromatic Ring of Endomorphins 1 and 2 Using an Atypical Constrained C Terminus</title><author>Yu, Ye ; Shao, Xuan ; Cui, Yun ; Liu, Hong-mei ; Wang, Chang-ling ; Fan, Ying-zhe ; Liu, Jing ; Dong, Shou-liang ; Cui, Yu-xing ; Wang, Rui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4064-46bc7129985673ea741a0da7f1ad4b952e69ba577e87dd5d724d1313d43bcd823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Amides - chemistry</topic><topic>Amino Acid Sequence</topic><topic>Analgesics, Opioid - chemistry</topic><topic>Analgesics, Opioid - pharmacology</topic><topic>Animals</topic><topic>Drug Design</topic><topic>endomorphins</topic><topic>Guinea Pigs</topic><topic>Hydrocarbons, Aromatic - chemistry</topic><topic>Ileum - drug effects</topic><topic>Ileum - physiology</topic><topic>Male</topic><topic>Mice</topic><topic>Molecular Sequence Data</topic><topic>Oligopeptides - chemistry</topic><topic>Oligopeptides - pharmacology</topic><topic>opioid receptors</topic><topic>Protein Conformation</topic><topic>Receptors, Opioid - agonists</topic><topic>Receptors, Opioid - metabolism</topic><topic>Receptors, Opioid, mu - agonists</topic><topic>Receptors, Opioid, mu - metabolism</topic><topic>spatial arrangements</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>synthesis</topic><topic>Vas Deferens - drug effects</topic><topic>Vas Deferens - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Ye</creatorcontrib><creatorcontrib>Shao, Xuan</creatorcontrib><creatorcontrib>Cui, Yun</creatorcontrib><creatorcontrib>Liu, Hong-mei</creatorcontrib><creatorcontrib>Wang, Chang-ling</creatorcontrib><creatorcontrib>Fan, Ying-zhe</creatorcontrib><creatorcontrib>Liu, Jing</creatorcontrib><creatorcontrib>Dong, Shou-liang</creatorcontrib><creatorcontrib>Cui, Yu-xing</creatorcontrib><creatorcontrib>Wang, Rui</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ChemMedChem</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Ye</au><au>Shao, Xuan</au><au>Cui, Yun</au><au>Liu, Hong-mei</au><au>Wang, Chang-ling</au><au>Fan, Ying-zhe</au><au>Liu, Jing</au><au>Dong, Shou-liang</au><au>Cui, Yu-xing</au><au>Wang, Rui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure-Activity Study on the Spatial Arrangement of the Third Aromatic Ring of Endomorphins 1 and 2 Using an Atypical Constrained C Terminus</atitle><jtitle>ChemMedChem</jtitle><addtitle>ChemMedChem</addtitle><date>2007-03-12</date><risdate>2007</risdate><volume>2</volume><issue>3</issue><spage>309</spage><epage>317</epage><pages>309-317</pages><issn>1860-7179</issn><eissn>1860-7187</eissn><abstract>The discovery of endomorphins (EMs) has opened the possibility of searching for new analgesics. However, the design of peptide analgesics has proven to be very difficult as a result of their conformational flexibility and a lack of clarity in structure–activity relationships (SAR). In EMs, the amino acid side chains exhibit considerable conformational flexibility, especially in the third aromatic ring, which is free to adopt a bioactive conformation. To resolve these problems, a series of C terminus EM analogues, [Xaa4‐R]EMs, modified through the substitution of Phe4 with nonaromatic residues and termination with benzyl groups, were designed to generate conformational constrains of the third aromatic ring by amide bond and torsion angles (ϕ4 and ψ4) of Xaa4. Introduction of (S)‐α‐methyl or (S)/(R)‐α‐carboxamide on the methylene unit of the benzyl group was designed to produce an atypical topographical constraint (ϕ5) of the third aromatic ring rotation. Interestingly, some EM derivatives, with elimination of the C‐terminal carboxamide group and significant changes in the address sequence (Phe4‐NH2), still exhibited higher μ‐opioid receptor (MOR) affinity than unmodified EMs. In contrast, some analogues with incorrectly constrained C termini displayed very low affinity and pharmacological activities. Thus, our results indicate that these EM analogues, with atypical constrained C termini, provide model compounds with potent MOR agonism. They also give evidence that the proper spatial orientation and conformational restriction of the third aromatic ring are crucial for the interaction of EMs with MOR. The C termini of endomorphin analogues, [Xaa4‐R]EMs, modified by substitution of Phe4 with nonaromatic residues and terminated with benzyl groups, were designed to generate conformational constrains of the third aromatic ring by amide bond and torsion angles (ϕ4 and ψ4) of Xaa4.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>17285661</pmid><doi>10.1002/cmdc.200600274</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1860-7179
ispartof ChemMedChem, 2007-03, Vol.2 (3), p.309-317
issn 1860-7179
1860-7187
language eng
recordid cdi_proquest_miscellaneous_70386070
source Wiley
subjects Amides - chemistry
Amino Acid Sequence
Analgesics, Opioid - chemistry
Analgesics, Opioid - pharmacology
Animals
Drug Design
endomorphins
Guinea Pigs
Hydrocarbons, Aromatic - chemistry
Ileum - drug effects
Ileum - physiology
Male
Mice
Molecular Sequence Data
Oligopeptides - chemistry
Oligopeptides - pharmacology
opioid receptors
Protein Conformation
Receptors, Opioid - agonists
Receptors, Opioid - metabolism
Receptors, Opioid, mu - agonists
Receptors, Opioid, mu - metabolism
spatial arrangements
Stereoisomerism
Structure-Activity Relationship
synthesis
Vas Deferens - drug effects
Vas Deferens - physiology
title Structure-Activity Study on the Spatial Arrangement of the Third Aromatic Ring of Endomorphins 1 and 2 Using an Atypical Constrained C Terminus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T20%3A48%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure-Activity%20Study%20on%20the%20Spatial%20Arrangement%20of%20the%20Third%20Aromatic%20Ring%20of%20Endomorphins%201%20and%202%20Using%20an%20Atypical%20Constrained%20C%E2%80%85Terminus&rft.jtitle=ChemMedChem&rft.au=Yu,%20Ye&rft.date=2007-03-12&rft.volume=2&rft.issue=3&rft.spage=309&rft.epage=317&rft.pages=309-317&rft.issn=1860-7179&rft.eissn=1860-7187&rft_id=info:doi/10.1002/cmdc.200600274&rft_dat=%3Cproquest_cross%3E70386070%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4064-46bc7129985673ea741a0da7f1ad4b952e69ba577e87dd5d724d1313d43bcd823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70386070&rft_id=info:pmid/17285661&rfr_iscdi=true